New patent for the Marius Pharms drug KYZATREX – DrugPatentWatch
Annual Drug Patent Expiration for KYZATREX
Kyzatrex is a drug marketed by Marius Pharms Llc and included in one NDA. It is available from a single supplier. There are two patents protecting this drug.
This drug has eighteen patent family members in eleven countries.
The generic ingredient in KYZATREX is testosterone undecanoate. One registered supplier for this compound. Additional details are available on the testosterone undecanoate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
Make Better Decisions with DrugPatentWatch
» Start Your Free Trial Today «
Copyright © DrugPatentWatch. Originally published in New patent for the Marius Pharms drug KYZATREX
